Literature DB >> 6299943

Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

M Kaku, K Yagawa, S Nagao, A Tanaka.   

Abstract

Muramyl dipeptide (MDP) and lipopolysaccharide (LPS) from Escherichia coli were tested for the ability to influence superoxide anion (O2-) release from guinea pig phagocytes. Both MDP and LPS alone did not, by themselves, stimulate O2- release by macrophages and polymorphonuclear leukocytes. However, the preincubation of macrophages with MDP or LPS primed the macrophages to release an enhanced amount of O2- when stimulated by cytochalasin E and wheat germ agglutinin. When polymorphonuclear leukocytes were treated in the same way, only LPS showed an enhancing effect. MDP enhanced NADPH oxidase activity of macrophages, which is probably the reason for enhanced O2- release by MDP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299943      PMCID: PMC347987          DOI: 10.1128/iai.39.2.559-564.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

2.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

Review 3.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

4.  Histochemical studies relating the activation of macrophages to the intracellular destruction of tubercle bacilli.

Authors:  M Ando; A M Dannenberg; M Sugimoto; B S Tepper
Journal:  Am J Pathol       Date:  1977-03       Impact factor: 4.307

5.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

6.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

7.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

8.  The binding of human and guinea-pig IgG subclasses to homologous macrophage and monocyte Fc receptors.

Authors:  M D Alexander; J A Andrews; R G Leslie; N J Wood
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

9.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering.

Authors:  C F Nathan; R K Root
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  24 in total

1.  Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides.

Authors:  C Jupin; M Parant; L Chedid; C Damais
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

Review 2.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

3.  Enhanced killing of Candida albicans by cultured peritoneal exudate cells treated with SM-1213, a synthetic immunomodulator.

Authors:  C J Morrison; P Gordon; T Hashimoto
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.

Authors:  S Hashimoto; K Nomoto; T Matsuzaki; T Yokokura; M Mutai
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.

Authors:  K N Masihi; W Lange; B Rohde-Schulz; L Chedid; M Jolivet
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Biphasic effects of muramyl dipeptide or lipopolysaccharide on superoxide anion-generating activities of macrophages.

Authors:  K Yagawa; M Kaku; Y Ichinose; S Nagao; A Tanaka; A Tomoda
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.

Authors:  S Nagao; M Nakanishi; H Kutsukake; K Yagawa; S Kusumoto; T Shiba; A Tanaka; S Kotani
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

8.  Qualitative detection of muramic acid in normal mammalian tissues.

Authors:  Z Sen; M L Karnovsky
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Phorbol myristate acetate-induced modulation of antibody-dependent cellular cytotoxicity by human polymorphonuclear leukocytes.

Authors:  Y Ichinose; K Yagawa; M Kaku; N Hara; M Ohta
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

10.  The reduction of inflammatory responses in lipopolysaccharide-tolerant eyes.

Authors:  P Bhattacherjee; A Parke
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.